APA (7th ed.) Citation

A, M., L, N., A, C., L, L., R, L. R., C, I., . . . F, F. (2010). Telbivudine use in a patient affected by occult hepatitis B virus and B-cell non-Hodgkin lymphoma. Leukemia & lymphoma, 51(3), 554. https://doi.org/10.3109/10428190903553961

Chicago Style (17th ed.) Citation

A, Montineri, Nigro L, Chiarenza A, Larocca L, La Rosa R, Iacobello C, Di Raimondo F, and Fatuzzo F. "Telbivudine Use in a Patient Affected by Occult Hepatitis B Virus and B-cell Non-Hodgkin Lymphoma." Leukemia & Lymphoma 51, no. 3 (2010): 554. https://doi.org/10.3109/10428190903553961.

MLA (9th ed.) Citation

A, Montineri, et al. "Telbivudine Use in a Patient Affected by Occult Hepatitis B Virus and B-cell Non-Hodgkin Lymphoma." Leukemia & Lymphoma, vol. 51, no. 3, 2010, p. 554, https://doi.org/10.3109/10428190903553961.